fexofenadine has been researched along with Fatty Liver in 1 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raveendran, VV | 1 |
| Kassel, KM | 1 |
| Smith, DD | 1 |
| Luyendyk, JP | 1 |
| Williams, KJ | 1 |
| Cherian, R | 1 |
| Reed, GA | 1 |
| Flynn, CA | 1 |
| Csanaky, IL | 1 |
| Lickteig, AL | 1 |
| Pratt-Hyatt, MJ | 1 |
| Klaassen, CD | 1 |
| Dileepan, KN | 1 |
1 other study available for fexofenadine and Fatty Liver
| Article | Year |
|---|---|
H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Ca | 2014 |